RxDoctor Payments Data

Hyman Kirschenbaum, MD

Gastroenterology · New York, NYNPI 1063405900

Payments from drug & device makers

$1,466in general payments, 2019–2025

Across 86 payments — averaging $17.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$683
  • Gilead$273
  • Braintree Laboratories, Inc.$124
  • Janssen Scientific Affairs, LLC$120
  • Redhill Biopharma Inc.$78
  • Takeda Pharmaceuticals U.S.A., Inc.$65
  • plus $123 from 5 others

What the payments were for

  • Consulting fees$151%
  • Food & beverage$1,45199%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,466 in reported general payments places this provider in the 40th percentile of 1,682 gastroenterology providers in New York.

See all gastroenterology providers in New York

Medicare billing

Part B allowed, 2024
$17,715
Medicare patients
60
Services billed
134

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Famotidine244$3,809
Lubiprostone19$1,847
Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg85$1,599
Omeprazole65$713
Sucralfate15$480
Pantoprazole Sodium71$406
Esomeprazole Magnesium15$366
Dicyclomine Hcl24$361
Hydrocortisone16$228
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl12$221
Procto-Med HcHydrocortisone11$110
Ondansetron Hcl20$26

Paid to pharmacies, not to this prescriber.

Other gastroenterology in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →